Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
NCT04808323Phase 1Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2021
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial in rectal adenocarcinoma (3 cohorts), sponsored by Medical College of Wisconsin. Primary endpoint: Serious Adverse Events at 12.1 weeks. Started Jun 2021; status: recruiting.
02
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT04808323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808323.